Form 4: Intuitive Surgical Executive Chair Sells Shares
Insider Transaction Report
Intuitive Surgical's Executive Chair, Gary S. Guthart, exercised stock options and subsequently sold a portion of the acquired common stock under a Rule 10b5-1 trading plan.
Summary
- Gary S. Guthart, Executive Chair of the Board and Director of Intuitive Surgical Inc. (ISRG), reported transactions on December 1, 2025.
- Guthart exercised 25,500 non-qualified stock options at an exercise price of $139.52 per share.
- Immediately following the exercise, 22,806 shares of common stock were sold at a weighted average price of $570.8902 per share.
- The sales occurred in multiple transactions ranging from $568.62 to $573.54 per share.
- These transactions were conducted in accordance with a pre-arranged Rule 10b5-1 trading plan, which expires on April 28, 2026.
- Following these transactions, Guthart directly beneficially owns 2,694 shares of common stock.
- Indirect beneficial ownership includes 17,120 shares held by a Trust FBO Daughter, 17,120 shares held by a Trust FBO Son, and 1,231,890 shares held by a separate Trust.
Sentiment
Score: 6
Explanation: The filing reports an insider transaction involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. While insider selling can sometimes be viewed negatively, the pre-planned nature mitigates concerns about opportunistic timing. The transaction itself does not provide new information on company performance or outlook, thus a neutral to slightly positive sentiment due to the significant profit realized by the executive.
Positives
- The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned activity and reducing concerns about opportunistic insider selling.
- The exercise of options at a significantly lower price than the sale price demonstrates a substantial gain for the insider, reflecting the company's stock appreciation.
Negatives
- Insider selling, even under a 10b5-1 plan, reduces the direct equity stake of a key executive, which some investors might interpret as a slight reduction in direct alignment of interests.
Future Outlook
This Form 4 filing reports an insider transaction and does not contain specific forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
Intuitive Surgical is a leader in the robotic-assisted surgery market. Insider transactions like this are routine for executives in established, high-growth companies, often for personal financial planning and diversification, and are generally not indicative of changes in the company's competitive position or market trends.
Related Party Transactions
- Indirect beneficial ownership includes shares held in trusts for the reporting person's daughter and son, and a general trust.
Stakeholder Impact
- Shareholders may note the reduction in direct ownership by a key executive, though the pre-planned nature of the transaction under Rule 10b5-1 typically minimizes negative interpretations.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Next Steps
- The Reporting Person undertakes to provide full information regarding the number of shares sold at each respective price within the reported range upon request to the SEC staff, the Issuer, or a security holder.
Key Dates
| Date | Description |
|---|---|
| 02/15/2028 | Expiration date of the non-qualified stock option. |
| 12/01/2025 | Date of stock option exercise and subsequent sale of common stock. |
| 04/28/2026 | Expiration date of the Rule 10b5-1 trading plan. |
Recommendation
holdThis Form 4 reports a routine insider transaction involving the exercise of stock options and subsequent sale of a portion of the acquired shares under a pre-arranged 10b5-1 plan. Such transactions are common for executives for liquidity and diversification purposes and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing.
Keywords
Intuitive Surgical, ISRG, Form 4, Insider Transaction, Stock Option Exercise, Share Sale, Gary S. Guthart, 10b5-1 Plan, Robotic Surgery
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.